Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

1.90
-0.0900-4.52%
Post-market: 1.930.0300+1.58%19:51 EDT
Volume:98.58K
Turnover:190.27K
Market Cap:1.27M
PE:-0.04
High:2.05
Open:1.97
Low:1.90
Close:1.99
Loading ...
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 28, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Dec 15, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Dec 08, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 07, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Nov 28, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Oct 07, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Jun 23, 2023

Correspondence

Form CORRESP - Correspondence
Jun 16, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
May 25, 2023

Correspondence

Form CORRESP - Correspondence